Current status of gene therapy for cancer

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Cancer gene therapy has evolved significantly, encompassing immunogene, suicide, gene correction, and oncolytic modalities.
• Emerging strategies include gene suppression and microRNA (miRNA) therapies, focusing on enhanced target specificity and delivery.
• Current research aims to improve vector efficiency and overall therapeutic efficacy for various cancers.

Purpose of the Study:

• To review recent advancements in cancer gene therapy, including novel approaches and clinical studies.
• To highlight key developments in vector delivery and therapeutic efficacy.
• To identify promising future directions for preclinical and clinical cancer gene therapy research.

Main Methods:

• Review of current literature on cancer gene therapy.
• Analysis of progress in vector development and delivery systems.
• Evaluation of emerging therapeutic strategies like gene suppression and oncolytic viruses.

Main Results:

• Significant improvements in suicide, T-cell-based, and oncolytic virus therapies.
• Successful development of siRNA-based gene suppression therapies.
• Introduction of novel approaches such as transcription factor decoy oligonucleotides (ODNs).

Conclusions:

• Cancer gene therapy has progressed substantially, refining existing strategies and delivery mechanisms.
• The field is advancing towards treating disseminated metastases with gene-based therapies.
• Numerous novel gene therapy approaches are nearing translation into clinical trials.